Appropriateness of follow-up interval

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals